GlassScriptPhysician profile
Ergun Kocak
NPI 1043425028
$11,512.67
in general payments reported to CMS, 2019-2025
21 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,583 · 2020: $295 · 2021: $889 · 2022: $457 · 2023: $5,270 · 2024: $1,690 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $3,950 · Long Term Medical Supply Or Device Loan: $1,553 · Food and Beverage: $1,064 · Travel and Lodging: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $3,950.00 |
| Long Term Medical Supply Or Device Loan | $1,552.50 |
| Food and Beverage | $1,064.08 |
| Travel and Lodging | $722.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $4,554.71 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Vioptix INC | $2,649.99 | 2019-2023 | |
| Integra Lifesciences Corporation | $1,779.30 | 2021-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Axogen | $1,274.86 | 2019-2023 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Sientra, INC. | $529.22 | 2019-2022 | |
| Tela Bio, INC. | $208.82 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $83.83 | 2019-2022 | |
| Abbvie INC. | $71.76 | 2024-2025 | |
| Allergan, INC. | $56.78 | 2019-2022 | |
| Pfizer INC. | $51.90 | 2020-2022 | |
| Revance Therapeutics, INC. | $50.00 | 2025 | Daxxify |
| Ethicon US, LLC | $41.53 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $27.89 | 2022 | |
| Motiva USA, LLC | $23.27 | 2025 | |
| Stryker Corporation | $21.00 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $17.69 | 2019 | |
| Davol INC. | $16.48 | 2022 | |
| Baudax Bio INC. | $15.20 | 2022 | |
| W. L. Gore & Associates, INC. | $14.04 | 2021 | |
| Kerecis Limited | $12.71 | 2020 | |
| Medtronic, INC. | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ergun Kocak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.